Menu Icon Search
Close Search

About the ads

sbrt/srs +/- sensitizers/protectors

Discussion in 'Radiation Oncology' started by go hokies, 04.22.12.

  1. go hokies

    go hokies

    Joined:
    02.02.08
    Messages:
    8
    Status:
    Resident [Any Field]

    SDN Members don't see this ad. (About Ads)
    anyone aware of ongoing research/trials using radiation sensitizers or protectors concurrently with the delivery of SBRT/SRS?
  2. Gfunk6

    Gfunk6 Troublemaker Moderator Lifetime Donor

    Joined:
    04.15.04
    Messages:
    2,958
    Location:
    SF Bay Area
    Status:
    Attending Physician
    Physician PhD Faculty SDN 10+ Year Member
    Since both SRS and SBRT give near ablative doses which not only destroy the target but the vasculature as well, there is not a particularly good scientific rationale for radiosensitizers. When your radiation doses alone are not sufficient for LC (locally advanced H&N cancer, cervical cancer, GI cancers) then you toss in chemo for increased cell kill.

    Protectants are a bit more interesting. It seems only amifostine has panned out to administer during conventionally fractionated XRT. Since SRS and SBRT has strict size criteria however the chances of side effects (parenchymal necrosis, pneumonitis, RILD) are quite a bit lower.
    Last edited: 04.22.12
  3. RadRadRad

    RadRadRad

    Joined:
    08.24.10
    Messages:
    80
    Status:
    Resident [Any Field]
    SDN 2+ Year Member
    Can't think of any with true chemo on board, but a few with targeted agents come to mind

    BJU Int. 2011 Sep;108(5):673-8. doi: 10.1111/j.1464-410X.2010.09895.x. Epub 2010 Dec 13.
    Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma.

    Staehler M, Haseke N, Nuhn P, Tüllmann C, Karl A, Siebels M, Stief CG, Wowra B, Muacevic A.
    Source

    Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany. [email protected]
  4. RadRadRad

    RadRadRad

    Joined:
    08.24.10
    Messages:
    80
    Status:
    Resident [Any Field]
    SDN 2+ Year Member
    A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) Combined with Erlotinib for Patients with Recurrent Non-small Cell Lung Cancer (NSCLC)


    • B. Kavanagh
      • Affiliations
      • University of Colorado School of Medicine, Aurora, CO
      ,
    • R. Abdulrahman
      • Affiliations
      • University of Texas Southwestern, Dallas, TX
      ,
    • D.R. Camidge
      • Affiliations
      • University of Colorado School of Medicine, Aurora, CO
      ,
    • D.E. Gerber
      • Affiliations
      • University of Texas Southwestern, Dallas, TX
      ,
    • P.A. Bunn
      • Affiliations
      • University of Colorado School of Medicine, Aurora, CO
      ,
    • J. Schiller
      • Affiliations
      • University of Texas Southwestern, Dallas, TX
      ,
    • H. Choy
      • Affiliations
      • University of Texas Southwestern, Dallas, TX
      ,
    • L. Gaspar
      • Affiliations
      • University of Colorado School of Medicine, Aurora, CO
      ,
    • R. Doebele
      • Affiliations
      • University of Colorado School of Medicine, Aurora, CO
      ,
    • R.D. Timmerman
  5. Gfunk6

    Gfunk6 Troublemaker Moderator Lifetime Donor

    Joined:
    04.15.04
    Messages:
    2,958
    Location:
    SF Bay Area
    Status:
    Attending Physician
    Physician PhD Faculty SDN 10+ Year Member
    When I was a resident, my institution ran an investigator-initiated trial looking at concurrent erlotinib with SRS from NSCLC brain mets. All study endpoints negative.
  6. Wallachia

    Wallachia Member

    Joined:
    07.21.06
    Messages:
    67
    SDN 5+ Year Member
    does anybody still use amifostine? just curious
  7. medgator

    medgator Senior Member

    Joined:
    09.20.04
    Messages:
    1,669
    Status:
    Attending Physician
    SDN 10+ Year Member
    I've seen it used in some private practices. It's such a pain to use, especially with infusion-associated reactions that happen, especially the hypotension. I don't really see the point anymore, especially with IMRT for H&N.
  8. wagy27

    wagy27 SDN Mentor

    Joined:
    03.15.07
    Messages:
    1,030
    Status:
    Attending Physician
    SDN 7+ Year Member

    Agreed. Haven't really seen a large need for it with IMRT.

// Share //

Style: SDN Universal